The Effect of Magnesium Serum Levels on Clinical Outcomes in Patients With Acute Myocardial Infarction by Considering Desalination Drinking Water Levels Patients Fed From.
Sponsor study identifier
observational
150
1 country
1
Study Start
May 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 1, 2023
Actual (reported)Study Completion
December 1, 2023
Actual (reported)Association between serum magnesium and clinical outcome in patients with acute MI (AMI) with 1 year follow-up in 300 patients in regions supplied by desalinated drinking water (DSW) (Sheba MC) and 150 patients in regions with non-desalinated drinking water (DW) (Nahariya MC).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 4, 2014
Actual (reported)February 5, 2015
Actual (reported)May 2015
Date type not reportedThis date has not been verified as actual or estimated.
December 1, 2023
Actual (reported)December 1, 2023
Actual (reported)Number of Major Adverse Cardiovascular Events (MACE)
MACE including: acute infarct returns, revascularization, death within 30 days or one year, hospitalization for heart failure, hospitalization for angina pectoris and transient ischemic events.
1 year
Age
1 year
All Subjects 35-75 years of age with the first AMI will be prospectively recruited during 1 year from 2 regions; the Departments of Cardiology at the Sheba Medical center (300 patients, predominantly served by DSW) and the Nahariya Medical Center (150 patients, served by non-DSW).
Leviev Heart Center, Chaim Sheba Medical Center
Ramat Gan, Israel
Meital Shlezinger, PhDcandidate
Haim Sheba medical Center
150 participants (actual enrollment reported by the registry).
First Submitted
December 4, 2014
First Posted
February 5, 2015
Study Start
May 2015
Date type not reportedThis date has not been verified as actual or estimated.
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Contact the study team to confirm eligibility.
Primary Completion
December 1, 2023
Actual (reported)Study Completion
December 1, 2023
Actual (reported)Last Updated
December 12, 2023
Record last verified: 2023-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: